Carolina Haddad Martins

Carolina Haddad Martins

Auto-generated profile, based on publicly available information

Carolina Haddad Martins


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2026 in Brazilian Journal of Respiratory, Cardiovascular and Critical Care Physiotherapy
Verified
Journal Article
Open access
PDF file
MOMarilia Simone de Oliveira
Marilia Simone de Oliveira
CMCarolina Haddad Martins
Carolina Haddad Martins
DMDiego Campos de Moura
Diego Campos de Moura
LLLuanna Rodrigues Leite
Luanna Rodrigues Leite
EAEvanirso da Silva Aquino
Evanirso da Silva Aquino
Introdução: A Fibrose Cística (FC) é uma doença genética causada por mutações no gene regulador da transmembrana da fibrose cística -CFTR, sendo a mutação Delta F508 a mais prevalente e associada a formas mais graves. O tratamento fisioterapêutico é essencial no manejo da FC, mas a adesão costuma ser baixa, especialmente em pacientes com mutações severas. Objetivo: Verificar se há diferença na taxa de adesão ao tratamento fisioterapêutico entre diferentes categorias genotípicas e sua associação com exacerbações e função pulmonar. Métodos: Estudo descritivo, transversal e analítico com pacientes com FC de até 18 anos. Foram avaliadas a adesão relatada e aferida, o escore de Fuchs, a função pulmonar e o genótipo. As mutações foram classificadas em homozigose para Delta F508, heterozigose para Delta F508 e outras. A análise estatística utilizou Kolmogorov-Smirnov, correlação de Spearman e ANOVA com Bonferroni (α < 0,05). Resultados: Foram incluídos 108 pacientes, predominando homozigotos para Delta F508 (46,3%). As medianas de adesão relatada e aferida foram 8,0 e 8,5, respectivamente, e o escore de Fuchs foi 1,0. Não houve diferenças significativas entre as categorias genotípicas e a adesão (p > 0,05) nem com os Sinais Clínicos de Exacerbação (SCE). Observou-se, contudo, correlação negativa significativa entre adesão e SCE (r = -0,3; p < 0,01) e correlação positiva entre adesão e VEF1/CVF (r = 0,2 e 0,3; p < 0,05). Conclusão: A maior adesão ao tratamento fisioterapêutico associa-se à redução de exacerbações e à melhor preservação da função pulmonar, independentemente do genótipo.

8 October 2026 in Brazilian Journal of Respiratory, Cardiovascular and Critical Care Physiotherapy
Verified
Journal Article
Open access
PDF file
MOMarilia Simone de Oliveira
Marilia Simone de Oliveira
CMCarolina Haddad Martins
Carolina Haddad Martins
DMDiego Campos de Moura
Diego Campos de Moura
LLLuanna Rodrigues Leite
Luanna Rodrigues Leite
EAEvanirso da Silva Aquino
Evanirso da Silva Aquino
Background: Cystic fibrosis (CF) is a genetic disease caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator -CFTR gene, with the Delta F508 mutation being the most prevalent and associated with more severe clinical manifestations. Physiotherapeutic treatment is essential for CF management; however, adherence is often low, especially among patients with severe mutations. Aim: To verify whether there are differences in physiotherapy treatment adherence rates among different genotypic categories and to assess their association with pulmonary exacerbations and lung function. Methods: A descriptive, cross-sectional, and analytical study was conducted with CF patients aged up to 18 years. Reported and measured adherence, Fuchs score, pulmonary function, and genotype were evaluated. Mutations were classified as homozygous Delta F508, heterozygous Delta F508, or other mutations. Statistical analysis used the Kolmogorov–Smirnov test, Spearman correlation, and ANOVA with Bonferroni correction (α < 0.05). Results: A total of 108 patients were included, with Delta F508 homozygotes being predominant (46.3%). Median reported and measured adherence scores were 8.0 and 8.5, respectively, and the median Fuchs score was 1.0. No significant differences were observed between genotypic categories and adherence (p > 0.05) or clinical signs of exacerbation (SCE). However, a significant negative correlation was found between adherence and SCE (r = –0.3; p < 0.01) and a positive correlation between adherence and the FEV1/FVC ratio (r = 0.2 and 0.3; p < 0.05). Conclusion: Higher adherence to physiotherapeutic treatment is associated with fewer pulmonary exacerbations and better preservation of lung function, regardless of genotype.